MacroGenics | MGNX - Чистый доход





Чистый доход Изменить Дата
AbbVie USD 3.61B 2.92B 2026-06
Amgen USD 2.38B 556M 2026-06
AstraZeneca USD 2.51B 573M 2026-06
Biogen USD 97.5M 222M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Daiichi Sankyo JPY 68.64B 18B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Genmab DKK 303M 250M 2026-06
Geron USD -3.64M 27.5M 2026-03
Gilead Sciences USD -10.5B 12.52B 2026-06
J&J USD 5.53B 299M 2026-06
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
MacroGenics USD -36.77M 22.62M 2026-03
Merck USD -1.34B 2.9B 2026-06
Pfizer USD -248M 2.94B 2026-06
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 1.3B 569.7M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Xencor USD -21.73M 107.19M 2026-06